---
authors:
- Stewart-Lynch, Autumn
category: Case Study
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/37725467/
file_path: 2023/09/finerenone-kerendia-for-the-treatment-of-chronic-kidney-dise.md
issue: '3'
keywords:
- Diabetes Mellitus, Type 2
- Humans
- Patients
- Diabetes
- Renal Insufficiency, Chronic
- Naphthyridines
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Diabetes Mellitus, Type 2
- Naphthyridines
- Patients
- Renal Insufficiency, Chronic
original_format: PubMed
pages: 305-306
patient_population: Adults
peer_reviewed: true
pmid: '37725467'
processed_date: '2025-07-30'
publication_date: '2023-09-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-07-30'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Finerenone (Kerendia) for the Treatment of Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus.
topics:
- Diabetes Mellitus
- Endocrinology
- Family Medicine
- Metabolic Disorders
volume: '108'
---

# Finerenone (Kerendia) for the Treatment of Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus.

**Authors:** Stewart-Lynch, Autumn

**Published in:** American family physician | Vol. 108, No. 3 | 2023-09-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/37725467/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Diabetes Mellitus, Endocrinology, Family Medicine, Metabolic Disorders

## MeSH Terms

Humans, Diabetes Mellitus, Type 2, Naphthyridines, Patients, Renal Insufficiency, Chronic

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37725467/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
